Holen Sie sich die Stockscreener-App
1.46
4.58%
-0.07
Metavia Inc Aktie (MTVA) Neueste Nachrichten
MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon… - Yahoo Finance
MetaVia Inc. Reports Progress in Cardiometabolic Drug Development - MSN
Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy - TradingView
FY2029 Earnings Forecast for MetaVia Issued By HC Wainwright - Defense World
HC Wainwright Reaffirms “Buy” Rating for MetaVia (NASDAQ:MTVA) - Defense World
Positive Outlook on MetaVia’s Promising Pipeline and Strategic Growth Despite Market Challenges - TipRanks
MetaVia Inc (MTVA) Reports Q4 EPS of -0.59, Revenue at $0 Millio - GuruFocus
MetaVia Inc. (MTVA) reports earnings - Quartz
Bank of England leaves benchmark interest rate unchanged at 4.50% with inflation still high - 69News WFMZ-TV
Stock market today: Wall Street gives back some gains after the Fed extends interest rate pause - WFMZ.com
MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update - PR Newswire
Tonsil Removal Helps Kids With Snoring/Sleep Apnea - 69News WFMZ-TV
New Clot-Busting Drug Quicker And As Effective In Treating Stroke - 69News WFMZ-TV
Ears Ringing? Diet Changes Might Reduce Risk Of Tinnitus - 69News WFMZ-TV
Combination Therapy Recommended For Migraines - 69News WFMZ-TV
Dance Soothes Agitation In Alzheimer's Patients - 69News WFMZ-TV
MetaVia (MTVA) Expected to Announce Quarterly Earnings on Thursday - Defense World
Stock market today: Wall Street rises ahead of Fed announcement - 69News WFMZ-TV
Wall Street tumbles 10% below its record for first 'correction' since 2023 on Trump's trade war - 69News WFMZ-TV
Stocks' sell-off worsens as Wall Street wonders how much pain Trump will accept for economy - WFMZ.com
Stock market today: Wall Street ends its wild week with what else but more swings - WFMZ.com
New Biotech Stocks at Investorideas.com - Investorideas.com newswire
MTVA stock touches 52-week low at $1.48 amid sharp yearly decline - Investing.com Canada
MTVA stock touches 52-week low at $1.48 amid sharp yearly decline By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
NeuroBo Pharmaceuticals : Statement of Changes in Beneficial OwnershipForm 4 -July 28, 2022 at 09:34 pm EDT - Marketscreener.com
2024 Initations - Zacks Small Cap Research
Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025 - MSN
Biotech Advances Breakthrough Cancer Treatment Results - Streetwise Reports
MetaVia Advances Therapeutics with Promising Trial Updates - TipRanks
Walgreens tops Wall Street's expectations as drugstore chain continues turnaround plan - 69News WFMZ-TV
Greece bans windowless basements, freezes central Athens licenses in overhaul of short-term rentals - 69News WFMZ-TV
US added a strong 256,000 jobs in December as unemployment rate dipped to 4.1% - 69News WFMZ-TV
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference - The Herald Journal
Childhood Smoking Ups COPD Risk - 69News WFMZ-TV
Advisory firm recommends changes at Air Products - 69News WFMZ-TV
Can Doctors Estimate Life Expectancy After a Dementia Diagnosis? - 69News WFMZ-TV
Stock market today: World shares slide further as rate cut, tariff worries hit market sentiment - 69News WFMZ-TV
Tanker hit by Houthi rebels that threatened a Red Sea oil spill has been salvaged - 69News WFMZ-TV
How the wildfires in the Los Angeles area could affect California's home insurance market - 69News WFMZ-TV
Meloni says Italy is exploring deals on telecoms security, but denies private talks with Musk - 69News WFMZ-TV
Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports
Nearly half of Americans carry spare underwear for emergencies - 69News WFMZ-TV
‘Mufasa’ and ‘Sonic 3’ rule first weekend of 2025 - 69News WFMZ-TV
Pharma Innovator Unlocks Multi-Disease Treatment Potential - Streetwise Reports
Drug Innovator Launches Pivotal Cancer Trial Breakthrough - Streetwise Reports
Miami Biopharma Sells Part of Business & Begins New Clinical Trial - Streetwise Reports
What is HC Wainwright’s Estimate for MetaVia Q4 Earnings? - Defense World
Analysts Offer Predictions for MetaVia FY2024 Earnings - Defense World
Analyst Sees Major Growth for Biopharma With Weight-Loss Drug - Streetwise Reports
Analyst Initiates Coverage of Co. With 'Once-in-a-Generation' Drug - Streetwise Reports
MetaVia (NASDAQ:MTVA) Now Covered by Analysts at HC Wainwright - Defense World
MetaVia shares debut with Buy rating as DA-1726 shows preclinical weight-loss results - Investing.com Nigeria
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):